After-Hours Stock Movers 07/20: (SANM) (BSX) (CNI) Higher; (CYTR) (IBM) (SHAK) Lower (more…)

CytRx Corporation (Nasdaq: CYTR) 16% LOWER; announced its intention, subject to market and other conditions, to commence an underwritten public offering of its common stock. CytRx intends to use the net proceeds of the offering to fund clinical trials of its drug candidate aldoxorubicin and its drug discovery activities and for general corporate purposes, which may include pre-commercialization activities relating to aldoxorubicin, working capital, capital expenditures, research and development and other commercial